New!
Phase 1b determines optimal parameters for TRP-8803 use
Tryp Therapeutics completes Phase 1b study of TRP-8803, advancing to Phase 2 trials.
Tryp Therapeutics
Psilocin
Phase 1b Study
Clinical Trials
Biopharmaceutical
Posted on: 18/11/2024
Read More